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Summary 
/J2-Microglobulin-deficient  (Bzm -/-)  mice are reported to hck cell surface expression of major 
histocompatibility complex (MHC) class I molecules, CD8 + T cells, and the ability to mount 
MHC class I-specific T  cell responses.  We have observed that B2m  -/-  mice possess CD8 + 
T cells that can be induced to perform strong allospecific cytotoxic responses against nonself- 
MHC dass I by in vivo priming. We report that these B2m -/-  cytotoxic T lymphocyte (CTL) 
differ  from those induced in Bzm-positive  littermates in that  they cross-react  and kill calls 
expressing self-MHC class I at normal ligand density with ~2m. B2m  -/-  CTL could even 
be induced in primary mixed lymphocyte culture by sdf-MHC dass I expressing stimulator cells, 
whereas allogeneic stimulator cells failed to elicit a response under similar conditions. Cells with 
a reduced cell surface MHC class I expression were less sensitive, while syngeneic B2m  -/- 
cells were resistant  to the ~2m -/-  CTL. This antisdf-MHC reactivity could not be induced 
when ~/2m -/-  T  cells matured in an environment with normal MHC class I expression  in 
bone marrow chimeric mice. Antisdf-MHC reactivity was also observed against human peptide 
loading-deficient cells expressing the appropriate murine class I molecules, suggesting that affinity 
to sdf-MHC class I may occur irrespective of peptide content. The results fit with a model where 
positive and negative selection of CD8 + T  cells in B2m  -/-  mice is mediated by low levels 
of MHC class I free heavy chains. In this model, low ligand density on selecting cells leads to 
positive selection of rare T cells that bind to low levels of MHC class I free heavy chains, resulting 
in a very small peripheral CD8 + compartment. Due to low density of the selecting ligand, 
negative selection does not remove T cells recognizing Bzm-positive cells expressing self-MHC 
class I at normal ligand density, which generates a T cell repertoire that would be autoreactive 
in a B2m-positive littermate. The first "MHC deficient" animals thus paradoxically  provide a 
tool for direct demonstration and analysis of self MHC bias in the T  cell repertoire. 
M 
HC class I  molecules are expressed  on virtually all 
nucleated mammalian cells (1)./~2m,  the membrane- 
anchored heavy chain, and a short peptide are thought to 
assemble in the endoplasmatic reticulum where they form 
a complex that is transported to the cell surface (2). All three 
subunits are necessary for ef~dent transport and surface ex- 
pression of functional MHC class I  molecules. Cell lines 
ddident in/~2m express little ff any MHC class I molecules 
detectable by mAbs at the cell surface (3-5). Cells deficient 
in genes coding for transporter associated with antigen pro- 
cessing (TAP) 1 products involved in peptide loading also 
*  Abbra,  iation used in this  paper: TAP, transporter  associated with antigen 
processing. 
have a low surface expression of MHC class I (2, 6, 7). How- 
ever, several recent reports have indicated cell surface expres- 
sion of free MHC class I heavy chains without/~2m. Such 
free heavy chains can bind ~2m (5),  present exogenously 
added peptides to CTL (8),  and mediate positive sdection 
in fetal thymic organ cultures (9). In all these studies B2m 
had to be added exogenously for effects to be seen. 
Recent studies by Bix and Raulet (10), as well as by our- 
selves (11), indicate that strong MHC dass I allospeciiic CTL 
responses can be induced against B2m-deficient (B2m -/-) 
cells in the absence of exogenous B2m. CTL could be in- 
duced also against minor histocompatibility antigens, sug- 
gesting that free MHC class I heavy chains not only reach 
the cell surface in suf~dent amounts to be recognized by CTL, 
but that they are capable of presenting peptides (11). 
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normaUy conformed MHC class I molecules at the cell sur- 
face and they have a drastically reduced number of CD8 + 
T cells in the periphery (12, 13). This is regarded as a conse- 
quence of impaired positive selection in the absence of MHC 
class I molecules. In spite of this deficiency in CD8 + T ceUs, 
the mice reject  grafts and resist many virus infections sur- 
prisingly well (14-17).  In view of this, as weU as the recent 
observations that CD8 + T  calls can recognize/3zm  -/- 
cells in an MHC-spedfic or -restricted manner, we decided 
to investigate CD8 + T  cells and their specificity  in/3zm 
-/-  mice. We reasoned that if  free MHC class I heavy chains 
can reach the cell surface and be recognized by CTL, they 
may also play a role during sdection of CD8 + T  ceils. If 
indeed/3zm  -/-  mice would be able to positively sdect a 
pool of CD8 + T calls, it would be important to investigate 
tolerance, with respect to MHC class I of the sdf genotype, 
in order to assess the efficiency of negative selection. We ob- 
served  strong  allospecific  CD8 +  CTL  responses  in  ~2m 
-/-  mice, as recently also shown by Apasov et al. (18). Our 
study demonstrates that such CTL spedfacally  recognize MHC 
class I molecules not only of the appropriate allogeneic type 
used in the priming step, but also the self type when these 
are  expressed  with  /3zm at  normal  ligand  density.  Our 
results provide evidence for a functional sdection process of 
CD8 +  T  calls  in  /Szm -/-  mice resulting in  a  skewed 
repertoire with respect to tolerance to syngeneic MHC class 
I products. 
Materiah and Methods 
Mice.  All mice were bred and maintained at the Department 
of Tumor Biology, Karolinska Institutet.  The generation of the 
/32m -/-  mice has been described previously (19). We denote 
/~2m -/-  and/Szm +/-  for mice being homozygous or hetero- 
zygous for the ~2m mutation. The ~2m -/-  and the ~zm +/- 
mice used were (B6  x  129)Fz-Fs, and are of the H-2  s (K  s, D s) 
haplotype. C57B1/6 (]36), BALB/c, DBA, and AKK mice are of 
the H-2  s (K  s, Ds), H-2  a (K  a, D a, La), H-2  d, and H-2  s (K  k, D  k) 
haplotypes, respectively.  A/Sn carries the H-2' (K  t, 1Y, L  a) haplo- 
type. A.BY, A.CA, and A.SW are MHC congeneic mice of A/Sn 
background,  and are of the H-2  b,  H-2  f, and H-2' haplotypes, 
respectively. C57B1/10 (B10) is a substrain of B6. B10.D2 (K  a, D  a, 
L  d) and B10.A(2K) (K  k, D  s) are MHC congeuic B10 mice. Bone 
marrow chimeras were derived by 950-red irr~_~h~ion of the recip- 
ient mice and subsequent infusion of 5  x  106 i.v. donor bone 
marrow cells. The recipient mice were pretreated with 0.2 ml of 
ascites fluid of the NKI.1 CPK 136 hybridoma 1 d before infusion 
of donor bone marrow. 
Cell Lines.  P815  is a mastocytoma ~  line derived from DBA 
(H-2d), and P1HTR is a subline of P815. These two cell lines gave 
similar results, and both are, for reasons  of simplicity,  denoted 1)815 
in  the  tables of this  paper. PlHTK-K  s,  PlHTK-KKA,  and 
PlHTK-AAK are transfectants  of  PIHTK (20), and were the kind 
gift from Hans Stauss (University College, London, UK). KKA 
is an e~on-shuffled  construct containing the otl/c~2 domains of 
H-2K b, and the c~3 domain of HLA-A2. AAK is a construct con- 
taining the cd/tx2 domains of FILA-A2 and the ix3 domain of 
H-2KL FIHTK-D  s and PlHTR-KS-D  b are H-2D  b and H-~ b, D  b 
transfectants  of  PIHTK, respectively.  El.,4  is a ben~induced 
lymphoma derived from B6, and EI,4D  d is an H-2D  a transfectant 
of EL-4. C4.4-25-  is a/3zm  -/-  variant of EL-4, and E50.16  + 
is a/32m transfectant of C4.4-25-  (21). C4.4-25-D a is an H-2D a 
transfectant of C4.4-25-.  RMA is  a  subline of the  Raucher 
Virus-induced ]36 lymphoma RBL-5, and KMA-S is a TAP2 loss 
mutant of  RMA (2, 22-24). T2 is a hybrid between the two human 
cell lines .174 and CEM, and has an antigen processing deficiency 
due to a deletion in the MHC class II region, including the TAFI 
and TAP2 genes (6,  7).  T2-K  b, T2-D b, T2-D a, and T2-DP are 
MHC class I transfectants of T2, kindly provided by Peter Cress- 
well (Yale University School of Medicine, New Haven, CT). T1 
is the wild type of T2. T1-K  b and T1-D  a are MHC class I trans- 
fectants of T1. T1-K  s was kindly provided  by Frank Momburg and 
Gunther HLmmerling  (Deutsche Krebsforschungszentrum  DKFZ, 
Heidelberg, Germany). The generation of Con A-activated T cell 
blasts has been described (11). Briefly, 15  x  10  ~ erytbrocyte- 
depleted spleen cells were phted in each well in 12-well plates, in 
RPMI supplemented with 5/tg/ml Con A and 10% FCS. After 
2-3 d the bhsts were used as targets in a SlCr release assay. 
Transfection.  5-10 x  106 cells were suspended in 500/~1 of 
PBS. PIHTR and P1HTK-K  b were electroporated in with 10-20 
/zg of pSV2gptD  b phsmid (kindly provided by Ahin Townsend, 
Oxford University, England) at 250 V and 960/~F in a Genepulser 
(Bio-Rad Laboratories, Richmond,  CA).  For  selection of D  s- 
expressing transfectants,  cells  were stained  with MHC class I-specific 
mAbs  and  subsequently positively selected using  anti-mouse 
Ig-coated Dynabeads (Nycomed, Oslo, Norway). EI.,4, C4.4-25- 
and T1 were dectroporated  with 10-20/~g  of the pSV2neoD  d 
plasmid (kindly provided by Peter Robinson, Medical Research 
Council, London, UK) using 960/iF and 250, 250, and 210 V, 
respectively. Before positive selection as described above, transfor- 
taunts were selected  by growth in medium containing 0.5 mg/ml 
G418 (Sigma, Stockholm, Sweden). 
E.~ctor Cells and Mixed Lymphocyte Culture (MLC).  Mice  were 
immunized two to three times with 10 x  106 i.p. irradiated tumor 
or spleen cells. 60-70  x  106 spleen cells were restimulated in vitro 
with 5-8  x  106 tumor cells or 20-30  ￿  106 spleen cells (irradi- 
ated with 10,000 tad), in RPMI supplemented with 10% FCS and 
5  x  10 -s M 2-ME. After 5 d the cells were used as effector cells 
in a standard SlCr release assay. 
mASs, FACS  ~ Analysis, and Complement-mediated  Depletion of 
E~ctor Cell Populations.  For flow cytometry, FITC-conjugated 
mAbs directed against CD4 (YTS 191.1; Sera-Lab, Crawley Down, 
Sussex, England), CDS~x (169.4); TCK-od/~ (H57-597), or H-2K  s 
(53-6-7 and AF6-88.5; all from PharMingen, San Diego, CA) were 
used. Before FACS  |  analysis (on a FACS IV~ Becton Dickinson 
& Co., Mountain View, CA), cells were incubated with 1-2/tg 
of antibody (diluted in PBS to 100/~1) for 30--60 min at 4~  For 
complement-mediated effector cell depletion, the cells were first 
incubated in 100/zl/106 cells using a 100-~tg/ml mixture of two 
different mAbs (for CD4 depletion, 191.1 and 3.1.2.; and for CD8 
depletiun,  169.4 and  156.7.7). (These antibodies were kindly 
provided by Herman Waldman, University of Cambridge, Cam- 
bridge, UK). The cells  were then washed once and incubated with 
rabbit complement  (IS.l-Freeze  Biologicals,  Brown Deer, WI) diluted 
1:8 for 75-90 min at 37~  Hybridoma cells producing a mAb 
against H-2K  s,  D  b (28-8-6S; HB51) were  obtained from  the 
American Type Culture Collection (Kockvilh, MD). For deple- 
tion of H-2K  b, Db-expressing cells, 100 /tl/106 cells of protein 
A-purified antibody diluted to 20/~g/ml were used for the first 
incubation, followed  by incubation with complement as described 
above. 
Synthetic Poytides.  AU peptides were pro'chased from Chiton 
Mimotopes (Melbourne, Australia). The H-2K  s and H-2D  b bind- 
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of  Sendal and A/PR./8/34 influenza  viruses  and were: FAPGNYPAL 
and ASNENMETM (in single letter amino acid code). NH2 and 
COOH terminals were free in both peptides. 
Cold Target Competition Assa~  Effector  cens and cold (unlabeled) 
target ceils were mixed and preincubated in 37~  for 60 min be- 
fore addition of hot (StCr-labeled)  target cells. Tumor cells or Con 
A blasts were used as cold targets. The cold Con A blasts used 
as cold targets were not cytotoxic to any of the targets used (data 
not shown). 
Generation of Fibrosarcomas  from/~zm  -/-  and ~2m  +/-  Mice. 
Mice were injected intramuscularly with 0.05 mg of methylcholan- 
trene dissolved in 0.1 ml olive oil. Fibrosarcomas developed after 
a period of 3-5 too. The tumors were adapted to in vitro culture 
and typed by Southern blot analysis for the/3zm genotype. 
Resuks 
Generation  of AUospecific  CD8 +  CTL from  ffzm  -~- 
Mice  After in vivo priming and in vitro restimulation with 
BALB/c (H-2  d) or A/Sn (H-2*) spleen cells,/3zm  -/-  (H- 
2  b)  responder  mice developed  strong  cytotoxic responses 
against  the allospedfic H-2  d (or  H-2D  d only)-expressing 
targets (Tables 1 and 2). The strength of the response was 
in the same range as that of effector cells derived from/3zm 
+/-  or B6 control mice. The response was not dependent 
on epithelial cells or professional antigen-presenting cells 
among the allogeneic splenocytes used for priming and restim- 
uhtion, as these could be substituted by the H-2a-expressing 
tumor  P815,  a  CD4-CD8-  mastocytoma (Tables  1-3). 
However, the response was dependent on in vivo priming, 
since it was poor when unprimed spleen cells were used, as 
observed previously (data not shown, and reference 13). The 
CTL responses of/52m  -/-  mice have been observed in 
>30 consecutive experiments. 
The in vivo priming of/~zm -/-  mice resulted in a small 
but consistent increase in the number of CD8 + cells in the 
spleen so that these represented up to 3% of total spleen cells 
(not immunized: mean 1.1% CD8 + cells, range 0.2-1.6; im- 
munized: mean 2.8% CD8 + cells, range 1.7-5.3).  It should 
be noted that in absolute numbers the figures correspond to 
2-5  ￿  106  CD8"  cells  and an increase of approximately 
twofold of the whole CD8 + population as a response to in 
vivo priming. A more dramatic effect was noted at the end 
of the in vitro restimulation, when/~2rn  -/-  CD8 + cells 
had expanded 4-10-fold to represent up to 34% of total cells 
in the culture (Fig.  1). The CD8 + cells in this population 
were also TCIL-oe/O + , and the majority of the CD8-TCK- 
ce//3 + were CD4 + (Fig.  1 and data not shown). The cyto- 
toxic/52m  -/-  effector cells were CD4-CD8 § , as deter- 
mined by antibody and complement depletion of effector cells 
generated in the MLC (Table 1), and MHC class I allospecific 
since they killed human T1  or T2  cells  transfected with 
H-2D  a, but not untransfected cells (Tables 2 and 4). CD4 + 
calls also expanded upon secondary in vitro allostimulation 
of/32m  -/-  spleen cells, which contrasted to the decreased 
proportion of CD4 + cells in the corresponding cultures of 
spleen cells from in vivo primed O2m  +/-  mice (data not 
shown). However, depletion of CD4 + ceils had no effect on 
allospecific  cytotoxidty in  this  experimental system. /32m 
-/-  CTL generated by allogeneic stimulation thus behaved 
as expected from classical MHC-specific alloreactive CTL, 
with respect to phenotype and MHC  class I--oriented al- 
lospedficity. 
CTL Generated from ~zm  -/-  (1"1-2  b) Mice Cross-react on 
Cells Expressing H.2  ~.  In contrast to the effector cells gener- 
ated from the/~2m  +/-  litterrnates, anti-H-2a-primed/~zrn 
-/-  CTL also killed target cells with call surface expression 
of H-2  b (i.e.,  self) and/32m at normal ligand density (H- 
2b//Szm) (Tables 1 and 2). This killing was dependent on a 
normal MHC class I expression since the/3zm  -/-  mutant 
of EL-4, C4.4-25-,  was resistant, while the/3an transfec- 
taut of C4.4-25-,  with restored MHC class I  expression, 
was sensitive (Table 2). Furthermore, T2-K  b cells were killed 
whereas T2 and T2-Dp were not (Table 2). When Con A 
blasts derived from MHC congeneic mice were used as targets, 
anti-H-2  a/~an  -/-  CTL showed a preference for Con A 
blasts expressing H-2  b antigens, whereas the syngeneic/~zm 
-/-  (H-2  b)  Con  A  blasts  were resistant  (Table  2).  The 
Table  1.  Subset Depletion of /~2m +/-  and /~2m -/-  Effector Cells: Effector Cells from/~2m  -/-  Mice Are CD8 § and Haue a 
Broader Specificity 
Effector  cells*  Effector  cell  treatment and targets* 
P815  EL-4 
Responder  Priming in  Kestimulation 
mouse  vivo  in vitro  C'  CD4 + C'  CD8 + C'  C'  CD4 + C'  CD8 + C' 
~2m  +/-  A/Sn  A/Sn  49, 30s  51, 42  3, 0  0, 0  0, 0  0, 0 
~-n  -/-  A/Sn  A/Sn  34, 18  38, 21  2, I  44, 32  44, 35  2, 2 
8~,n -/-  P815  P815  77, 69  76, 59  17, 7  44, 34  37, 27  3, 3 
*  Effector  cells  were generated  as described  in Materials  and Methods. A/Sn splenocytes  or P815 tumor cells  were used  for  priming. 
The effector  cell  population  was depleted  from various  cellular  subsets  using  antibody  and complement treatment.  The EL-4 and P815 targets  are 
of H-2  b  and H-2  a haplotype,  respectivdy. 
$  Percent  specific  lysis  in a sICr  release  assay.  E/T ratio:  60:1,  12:1. 
663  GIas  et al. Table  2.  Specificity of CTL Generated  from ~2m  +/-  and ~2m  -/-  Mice 
Effector cells"  Target cells+ 
Priming in vivo 
and restimulation  BALB/c  EL-4  C4.4-25-  E50.16 § 
Exp.  Responder mice  in vitro  H-2  ds  H-2  b  H-2  b,  B2m-  H-2  b,  B~m § 
B2m  +/-  BALB/c  72,  62 tl  5,  0  1,  0  0,  0 
B2m  -/-  BALB/c  65,  52  61,  46  4,  0  62,  36 
P815  T2  T2-D  a  T2-K  b  T2-DP 
H-2  a  H-2D  d  H-2K  b  H-2DP 
/~2m +/-  P815  81,  60  0,  4  57,  26  9,  7  8,  1 
~zm  -/-  P815  80,  53  7,  8  41,  25  44,  23  19,  6 
BALB/c  B6  ~2m  -/-  A.BY  A.CA  A.SW 
H-2  d  H-2  b  H-2  b  H-2  b  H-2  f  H-2' 
3  B2m  -/-  P815  49,  50  28,  35  10,  7  39,  42  6,  6  0,  2 
/~2m  -/-  ccCD8~  P815  0,  1  7,  4  1,  0  ND  0,  1  0,  0 
P815  ILMA  B10.D2  B10.A(2R)  B10.BR 
H-2  d  H-2  b  H-2  d  H-2KtD  b  H-2  ~ 
4  ~2m  +/-  P815  75,  59  9,  0  69,  59  22,  0  34,  14 
~2m  -/-  P815  75,  69  84,  83  56,  61  45,  43  19,  3 
* Effectors were generated as described in Materials and Methods. 
* Target cells in Exps. 1, 3, and 4 were tumor cells or Con A blasts generated from the mouse strains indicated. In Exp. 2 only tumor cell targets 
were used. 
S The murine MHC class I genotype  is indicated below the name of the target  cell. 
II Percent specific lysis in a mCr release assay. E/T ratios were 60:1, 12:1 (Exp. 1); 40:1, 8:1 (Exp. 2);  10:1, 2:1 (Exp. 3);  8:1, 1.6:1 (Exp. 4). 
￿82  Effectors depleted in vitro with CD8 mAb and complement. 
Table  3.  Sensitivity of RMA-S  Cells to ~2m  -/-  CTL after Incubation in the Presence of Peptides or at Reduced Temperature 
Effector cells*  Target cells 
Priming in vivo 
Kesponder  and restimulation  P815  EL-4  C4.4-25-  RMA  RMA-S  RMA-S 
Exp.  mice  in vitro  H-2  a*  H-2  b  H-2  b,  Bzm-  H-2  b  H-2  b,  TAP2-  peptideS 
RMA-S 
26ocII 
1  ~2m  +/-  P815  69,  42~  6,  0  0,  0  3,  0  4,  4  8,  10 
Bzm  -/-  P815  62,  53  61,  14  0,  0  63,  40  8,  6  54,  23 
2  ~2m  +/-  P815  82,  82  14,  6  1,  2  23,  15  3,  6  n.t. 
Bzrn  -/-  P815  79,  86  66,  59  0,  1  72,  73  38,  24  n.t. 
n.t. 
n.t. 
10,  4 
83,  71 
* Effector cells were  generated  as described in Materials and Methods. 
MHC genotype and mutant characteristics are indicated below the name of the target  cell. 
S RMA-S was incubated at 37~  in a mixture 20 #M of Sendai (K  b binding) and influenza (D  b binding) peptides. 
It RMA-S was cultured  overnight at 26~ 
￿82  Percent specific lysis in a Cr release assay. E/T ratio  in both Exps.  1 and 2: 40:1,  8:1. 
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Figure 1.  Expansion of CD8+TCR  - 
(x/0 + cells after allostimuhtion  of in vivo 
primed ~3zm -/-  or B6 mice. ~zm -/- 
or B6 mice were primed  in vivo with ir- 
radiated I~LB/c 0-[-2  a) spleen cells, and 
subsequently  responder  cells were stained 
with FITC-conjugated  anti-CD8 and anti- 
TCR-a/3 mAb before and after in vitro 
restimuhtion. Both B6 (A and B) and 
O2m -/-  (C and D) spleen  ceils were as- 
say~ in parallel. The numbers  in each  quad- 
rant indicate  the percentage  of cells in the 
quadrant. 
killing  of H-2b-expressing  targets  was  also  mediated by 
CD4- CD8 + cells, as determined by complement-mediated 
depletion of the effector cell population (Table 1). To study 
whether this killing was due to a unique cross-reactivity be- 
tween H-2  b and H-2  a (as discussed in reference 25) we also 
generated Earn  -/-  CTL against AKR (H-2  k) or A.SW 
(H-2') spleen cells.  The same pattern emerged: Ezra  -/- 
(but not Ezra  +/-)  CTL killed targets expressing H-2b/ 
Ezra (data not shown). 
CTL Killing Induced by Peptide or Cold Temperature Treat- 
ment of RMA-S.  The peptide loading (TAP2)-deficient mu- 
tant RMA-S (H-2b; references 2, 22-24) showed a low and 
somewhat variable sensitivity (range: 5-38% lysis) to the anti- 
H-2d-stimulated Ezm  -/-  CTL.  RMA-S was dearly less 
sensitive than the wild type RMA line (50-80% lysis; Table 
3), but neither tLMA nor RMA-S were sensitive to anti- 
H-2  d Earn  +/-  CTL (Table 3). Culture of ILMA-S at 26~ 
or in the presence of H-2K  b and H-2D  b binding synthetic 
peptides significantly increased the sensitivity of KMA-S to 
the Ezra  -/-  CTL, but not to Ezm  +/-  CTL. Both of 
these treatments stabilize MHC class I molecules at the sur- 
face of tLMA-S and increase their steady state expression (2, 
26).  The ceU surface MHC class I levels induced by these 
treatments correspond to about half of what is expressed on 
wild type RMA cells. These observations suggest that E2m 
-/-  CTL can recognize H-2K  b and H-2D b molecules in- 
dependently of specific peptides loaded internally in the MHC 
class I peptide presentation pathway, and that ligand density 
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of MHC class I molecules may be crucial when they recog- 
nize cells expressing H-2b/fl2m. 
Specificity for Both  1-1-2  a and 1-1-2  b among  Individual ffzm 
-/-  (1"1-2  b) CTL.  We performed cold target competition 
experiments to test whether the killing of the allospecific 
H-2  d and the self-H-2b-expressing target was mediated by 
the same CTL. Bulk Ezm -/-  CTL generated against 1)815 
(H-2  a)  kiUed EL-4  (H-2  b)  as weU as P815-1abeled  targets 
(Table 4). Using EL-4 as a hot target, we observed that both 
EL-4 and P815, but not the Ezm -/-  C4.4-25-, competed 
for these Ezra  -/-  CTL  (Table 4).  This shows that the 
bulk population contained CTL able to recognize the self- 
MHC-matched as well as the allospecific target. Using P815 
as hot target, competition was seen only with 1)815, whether 
Ezm -/-  or Ezm +/-  CTL were used (data not shown). 
Competition experiments were also made with Ezm  -/- 
CTL  generated against  AKK  (H-2  k)  spleen  cells.  These 
killed A.BY (H-2  b) in addition to AKK Con A blasts of the 
allospecific  H-2  k type.  Using A.BY as a hot target, both 
A.BY and AKR competed for these CTL, while third party 
A.CA (H-2  ~) Con A blasts did not (Fig. 2 A). When AKK 
Con A blasts were used as hot targets, A.BY Con A blasts 
competed partially for E2m  -/-  CTL  whih they corn- 
pletdy failed to  compete for  Ezra  +/-  CTL  generated 
under the same conditions (Fig.  2 B and data not shown). 
From the combined cold target competition experiments we 
conclude that anti-H-2a-primed CTL bnlk cultures gener- 
ated from Ezm  -/-  H-2  b mice contain CD8 + CTL that Table 4.  ~2m  -/-  CTL Generated against Targets Lacking ~2m 
Effector ceils*  Target ceUs$ 
Priming in vivo 
Responder  and restimulation  EL-4  EL-4 D d  C4.4-25-  C4.4-25-D  d  T1-K  b  T1-D  d 
Exp.  mouse  in vitro  H-2  b$  H-2  b  +  D a  H-2  b,  fl2m-  H-2  b,  flzm-  +  D a  T1  H-2K  b  H-2D  d 
fl2m  -/-  H-2  (b  x  d) F~,  44,  2511  39,  26  2,  2  5,  1  2,  0  5,  2  34,  7 
fl2m  -/-  H-2  (b  x  d) F1,  45,  24  44,  25  2,  0  42,  15  7,  1  33,  14  46,  22 
fl2m  +/- 
Target cells 
Eb4  C4.4-25 -  C4.4-25 -D  d  P815 
fl2m  -/-  P815  59,  55  1,  7  51,  23  86,  76 
Cold target  cells 
Cold target competition 
(Hot  target:  Eb4)  ED4  C4.4-25-  C4.4-25-D  a  P815 
fl2m  -/-  P815  0,  12,  581  0,  0,  0  0,  6,  46  24,  66,  96 
" Effector cells were generated as described in Materials and Methods. 
$ In both Ex-ps. 1 and 2, ED4, CA.4-25-, and C4.4-25-D  a target cells had been grown in serum-free medium for a period of >2 mo and the assay 
was performed in serum-free medium. The effector cells had been cultured in serum-containing  medium but were washed in PBS before the assay. 
S The routine MHC class I genotype is indicated below the name of the target  cell. 
U  Percent specific lysis in a slCr release assay. E/T ratio:  40:1, 8:1. 
I Percent inhibition of EI.,4 lysis, compared with ED4 lysis when no unlabeled targets were present. The E/T ratio was 4:1, and the killing of EI.,4 
without unlabeled targets was 33%. 
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Figure 2.  Cold target  competition using A.BY (A) or AKK (B) as 
slCr-hbded targets.  Effgctors were flzm  -/-  CTL generated  against 
AKR by in vivo priming and in vitro restimnlation and were used at an 
E/T ratio of 20:1. (,4) Unlabeled A.BY (H-2  b) and AKK (H-2k), but not 
A.CA (H-2~), Con A blasts compete with slCr-hbded A.BY Con A blasts 
for anti-H-2  k B2m  -/-  CTL (B) Unlabeled AKR and to a lesser ex- 
tent A.BY, but not A.CA, Con A blasts compete with SlCr-hbded AKK 
Con A bhsts for anti-H-2  k fl2ra -/-  CTL. The cold/hot target ratios 
are indicated. Cold targets in both A and B were: (,) A.BY, (0) A.CA, 
and (V) AKK Con A blasts. The Con A blasts were not r  to 
either the hot target or to C4.4-25- fl~'a -/-  tumor cells. The experi- 
ment was made in medium containing FCS. 
kill allospeciiic targets,  of which some (but not all) cross- 
react on H-2b/flzm-expressing  targets. 
Cross-reaction between H.2b/B2m Expressed at Normal Ligand 
Density and H-2IY Free MHC Class I Heavy Chains.  None 
of our fl2m -/-  target cells were recognized by ~zm  -/- 
CTL,  and it was therefore important to test whether the 
~2m  -/-  CTL could mediate cytotoxicity in a system de- 
void of fl~'n, excluding the involvement of fl~n-derived pep- 
tides. To test this, we used flzm -/-  EL-4 cells transfected 
with H-ZD a (i.e., C4.4-25-D a) as targets. When B2m -/- 
(H-2  b) CTL were generated by in vivo priming and in vitro 
restimulation with ~zm + H-2 bxa spleen cens, these were able 
to kill C4.4-25-  D a, but not C4.4-25-.  The ~2m  -/- 
CTL could thus perform H-2D d allospecific killing against 
a flzm  -/-  target (Table 4). This demonstrates that (a) flzm 
-/-  CTL can recognize targets independently of flzm as 
such, or of a fl2m-derived peptide, and (b) H-2D d expressed 
in ceils with and without flzm result in H-2D a sharing an- 
tigenic structures, since the spleen cells used for priming and 
restimulation  expressed  both  H-2D a  and  fl2m,  and  the 
targets expressed H-2D a but no fl~m. Note that the H-2D a- 
transfected as well as the nontran~  EL-4 cells were killed, 
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D d transfection./~2m -/-  CTL could thus distinguish be- 
tween H-2  b and H-2D  d when expressed in EL-4/32m  -/- 
cells, but not when expressed in ~2m-positive cells at normal 
ligand density. This was confirmed in cold target competi- 
tion experiments using/3zm  -/-  CTL generated against 
P815 (H-2d). Such CTL killed C4.4-25-D d as well as EL-4, 
but not C4.4-25-  cells (Table 4).  A substantial number of 
these CTL killed both C4.4-25-D a and EL-4, since unla- 
beled C4.4-25-D a ceils competed for labded EL-4 cells as 
efficiently as EL-4 itself, whereas nontransfected C4.4-25- 
cells did not compete (Table 4). 
CTL Elicited by Priming ~2m  --/-- 1-1-2  s Mice with ~2m- 
positive 1-1-2  b Cells.  We immunized/32m -/-  (H-2  b) mice 
with B6 spleen cells with subsequent in vitro restimnlation, 
to mount the response directly to H-2  b. This yielded effector 
cells capable of killing RMA as well as RMA-S and in addi- 
tion a fibrosarcoma line from a/3zm  +/-  mouse, whereas 
three similar fibrosarcomas from/~zm -/-  mice were resis- 
tant (Table 5, Exp.  1). MHC class I (K  b or D b) transfectants 
of the T2 cell line were sensitive but nontransfected T2 and 
T2-K  k were resistant; the/32m  -/-  CTL were thus MHC 
class I  (H-2D  b and H-2K  b) specific. The data further sup- 
port the notion that ~2m  -/-  mice possess CTL precursors 
that can recognize H-2  b MHC class I molecules indepen- 
dently of loaded antigen (Tables 2 and 5), since the routine 
MHC class I molecules in T2-D  b and T2-K  b are considered 
to be devoid of peptides (27). The data on the T2 transfec- 
tants, therefore, also argue against the possibility that the 
response  was directed against minor histocompatibility an- 
tigens not shared by the/3zm  -/-  and B6 mice. 
When  B6-derived  EL-4  tumor  cells  were used  as  im- 
munogens in  order  to  dicit  an  H-2b-restricted  CTL re- 
sponse in/$zm  +/-  mice, these CTL behaved differently 
from those induced in the same way from/3zm +/-  mice. 
The/32m  +/-  CTL killed EL-4 but not T1-K  b, presum- 
ably due to lack of tumor antigens (or other routine-specific 
peptides) expressed by EL-4 (Table 5, exp. 2).  In contrast, 
/32m -/-  CTL killed both EL-4 and T1-K  b as well as the 
antigen processing defective variant T2-K  b. This cytotoxicity 
was dependent on the c~l/cx2 domains of H-2K  b, as evident 
from testing P815 cells transfected with chimeric genes ob- 
tained  by  exon  shuffling between  HLA-A2  and  H-2K  b 
(Table 5,  Exp.  2). 
Generation of H-2b-specific ~2m  -/-  (H.2b) CTL in a Pri- 
mary  MLC  Using  Syngeneic  /~2m-positive Stimulator  Cells. 
Table  5.  Speci.fici~ of CTL Generated  from ~m  +/-  and ff2m -/-  Mice Immunized with H-2b-expressing Cells 
Effector cells"  Target cells 
Kesponder  Stimulator  T2-K  b  T2-D b  T2-K  k 
Exp.  mouse  cells  T2  H-2K  bt  H-2D b  H-2K  k 
1  /~zm  +/-  B6  2,  6S  0,  0  5,  3  0,  0 
~zm  -/-  ]36  3,  0  45, 25  26,  10  0,  0 
MbetaC =  MbetaD-  MbetaJ +  MbetaN - 
H-2  b, ~2m-  H-2  b, /32m-  H-2  b, /~2m  +  H-2  b, /~zm= 
/~zm +/-  B6  8, 0  7, 2  17, 9  0, 0 
/~zra -/-  B6  8, 0  3, 4  43, 35  0, 0 
EL-4  C4.4-25-  E50.16 +  T1 
H-2  b  H-2  b,  ~2m-  H-2  b,  ~zm + 
2  /32m +/-  EL-4  52, 34  11, 8  47, 35  0, 0 
/~2m  --/-  EL-4  61, 57  3,  1  78, 69  11, 6 
P815  P815-  P815-  P815- 
AAK  II  KKAI  K b 
H-2  d  H-2  d, A2/K  b  H-2  a, Kb/A2  H-2  a, K  b 
RMA  RMA-S 
H-2  b  H-2  b, TAP2- 
35,  19  4, 2 
74, 64  60, 50 
T1-K  b  T2-K  b 
H-2K  b  H-2K  b 
3,  1  24,  12 
52,  30  55,  23 
P815-  P815- 
D b  KbD  b 
H-2  a, D b  H-2  d,  K b, D b 
~on  +/-  EL-4  2, 0  18, 2  19,  16  12, 2  11, 5  28, 6 
/3zm -/-  EL-4  4, 0  16, 3  50, 20  39, 13  42, 12  71, 32 
" Effectors  were generated by in vivo priming, followed  by in vitro restimulation. 
* The murine MHC class I genotype of the target cell is indicated. 
$ Percent specific lysis in a Cr release assay. E/T ratios were: 40:1, 8:1 (Exp. 1) and 1.6:1, 0.32:1 (Exp. 2). 
! Chimeric H-2Kb/HLA-A2 molecule. 
667  Glas et al. Given the fact that fl2m -/-  (H-2  b) CTL cross-react on 
H-2b/fl2m-expressing cells, one would suspect specificity for 
H-2  b in  the  fl2m  -/-  CD8 +  spleen  cell  population  in 
general.  We tested if the flzm  -/-  spleen cells would in 
fact respond in a primary MLC against fl2m-positive H-2  b 
stimulator cells. For this we used fl2m  -/-  mice that had 
been backcrossed to  B6  (H-2  b) for five  generations  (fl2m 
-/-  B6 bc.5), fl~m  -/-  B6 bc.5 spleen cells generated al- 
most no cytotoxic response when stimulated with irradiated 
DBA (H-2  d) spleen cells,  which is in line with previously 
published  data  (13).  However,  a  strong  H-2b-specilic re- 
sponse developed when fl2m  -/-  B6 bc.5 spleen cells were 
stimulated with B6. This response was MHC class I specific 
since  EL-4,  but  not  C4.4-25-,  was  killed.  Furthermore, 
P815 (H-2  d) was resistant  while P815-KbD  b was killed (Table 
6). In reverse, normal B6 spleen cells generated a strong cyto- 
toxic response to DBA but not to syngeneic B6 spleen cells. 
This indicates  that  the frequency of T  cells  in fl2m  -/- 
mice with  specificity for self-MHC class  I/fl2m  is higher 
than that for allogeneic MHC dass I/fl2m, whereas the sit- 
uation is reversed in the fl2m-expressing mice. 
Absence of H-2b-speci.fic Cross-reactivity among ffzm  -/- 
CTL  Maturing  in  a ~2m-positive Host.  We  finally  asked 
whether the cross-reactive response to sdf-MHC class I mol- 
ecules was intrinsic  to flzm  -/-  CTL,  or if it was influ- 
enced by other host cells. We derived bone marrow chimeras 
by reconstituting  lethally irradiated  B6 (H-2  b) mice with 
flzm  -/-  bone marrow cells. Analysis of spleen cells from 
these chimeras  revealed  that  <5%  flzm-positive cells  were 
present (data not shown). The flzm  -/-  bone marrow al- 
most fully reconstituted the CD8 compartment, representing 
8-10%  of all spleen calls,  compared with flzm  +/-  mice 
that contain up to 15% CD8 + spleen cells. This implies that 
normal MHC class I expression on CD8 + T cells themselves 
is not needed for their devdopment, as previously observed 
in reference 28. After 8 wk, these mice, as well as flzm  -/- 
and flzm  +/-  control mice, were immunized  with  P815 
(H-2a),  and tested as described above for fl2m  -/-  mice. 
In vitro restimulation of spleen cells from chimeric mice gener- 
ated CTL that  killed the specific target,  P815,  as did fl2m 
+/-  CTL. The effector cells from the chimeric mice were 
H-2K  b and H-2D  b negative (Table 7). In contrast  to CTL 
from flzm  -/-  control mice, flzm  -/-  CTL that had ma- 
tured  in  fl2m-positive  hosts  did  not  kill  EL-4  cells,  sug- 
gesting that developmental events regulate the sdf-reactivity 
of flzm  -/-  CTL. 
Our results demonstrate that  strong CTL responses can 
be induced in flzm  -/-  mice by in vivo priming and sub- 
sequent in vitro restimulation with allogeneic cells. This is 
in line with  a recent report  (18) demonstrating  that  CTL 
can be induced in the peritoneal exudate of fl2m  -/-  mice 
by intraperitoneal inoculation of tumor cells. In addition, our 
results provide: (a) a clear demonstration,  through the use 
of MHC class  I-transfected (MHC class II negative) ceils, 
that CTL in fl2m  -/-  mice can spedfically recognize MHC 
dass I molecules, and (b) evidence that some allospecific flzm 
-/-  CTL cross-react specifically  on fl2m-positive calls ex- 
pressing  sdf-MHC class  I. 
There are at least three different explanations for the exis- 
tence of functional CD8 + CTL in fl2m  -/-  mice: (a) they 
do not arise from a CTL precursor pool present in the mice 
initially,  but are rather induced from immature CD8 +  CD4 + 
cells by the priming  procedure;  (b)  they represent  CD8 + 
cells that have matured and survived by chance, in a stochastic 
process independent of positive sdection by MHC class I mol- 
ecules;  and  (c)  they represent  a pool of CD8 +  CTL  pre- 
cursors sdected on low ligand density of H-2b-free heavy 
chains.  We believe our data support the last explanation, for 
reasons outlined in the following discussion. 
The current modds of T  cell sdection are based on the 
idea that TCRs with too high affinity for self-MHC are nega- 
tively selected, while those with low to intermediate affinity 
are positively selected (29, 30). There is evidence for a role 
of MHC-bound peptides in positive as well as negative selec- 
tion, even if these processes are not completely understood 
(31,  32).  However, TCR affinity to MHC plus peptide is 
not the only determining  factor; at  the cellular level,  total 
Table  6.  Cytotoxic Response  from ~2m  -/-  (1-1-2  b) Spleen Cells Stimulated with ~2m § (1-I-29 Cells without In Vivo Priming 
Effector cells*  Target cells 
In vitro  EL-4  C4.4-25-  P815 
Responder  stimulation  H-2  b*  H-2  b, fl2m-  H-2  d 
P815-KbD  b 
H-2d,Kb,D  b 
B6  DBA  14,  16  s  0, 0  51,  41  66, 48 
flam -/-  B6 bc.51  DBA  18,  10  0, 0  6,  4  20,  6 
fl2m -/-  B6 bc.5  B6  47,  35  0, 0  16, 6  51, 28 
* 80  ￿  10~ B2m -/-  136 be.5 or B6 spleen cells were stimulated in vitro for 5 d with 25  ￿  106 B6 or DBA spleen cells. 
The MHC class I genotype is indicated below the name of the target cell. 
$ Percent specific lysis in a SlCr release assay. E/T ratio: 80:1, 16:1. 
II flzm -/-  (H-2  b) mice backerossed five times to B6. 
668  Self Bias of the T Cell Repertoire Table  7.  Specificity  of E~ectors from ~2m + Chimeric Mice Reconstituted with ~2m  -/-  Bone Marrow 
Effector cells"  Target cells and effector cell treatment* 
Ikesponder  Priming in  Restimulation  P815  EL-4 
mouse  vivo  in vitro  C's  HB51 + C'  C'  HB51 + C' 
Bzm  +/-  P815  P815  73,  691  10, 4  0,  0  6,  2 
Bzm  -/-  P815  P815  58, 49  72,  57  27,  19  35,  19 
Bzm  -/-  : B61  P815  P815  46,  38  50,  32  0,  0  0,  0 
* Effector cells generated  as described in Materials and Methods. 
* The effector cell population was depleted from MHC class I-expressing cells by HB51  and complement.  The EL-4 and P815 target  cells were 
of H-2  b and H-2  d haplotype,  respectivdy. 
S Effector cell treatment. 
II Percent  specific lysis in a slCr release assay. E/T ratio: 40:1,  8:1. 
I Bone marrow chimera generated by inoculation of 5  x  106 flzm bone marrow cells into 950-rad irradiated B6 mice. 
avidity is also influenced  by the density of the selecting ligand 
and by accessory molecules such as CD4 and CD8 (33). This 
predicts that a dramatic reduction in the density of ligand 
on the selecting cells should readjust the sdection window 
such that there would be a reduced probability of finding 
T cell precursors with high enough avidity for positive selec- 
tion. At the same time there would be a reduced probability 
for negative selection of T cells, including those expressing 
TCR with considerable at~nity to self-MHC. These would 
escape elimination due to low total avidity. In other words, 
low MHC class I expression during T cell education would 
reduce the number of selected CD8 + cells, with the con- 
comitant possibility that the few ceils that are selected might 
cross-react specifically on self-MHC class I when these mole- 
cules are expressed at normal ligand density.  In contrast to 
the modds based on total absence of CD4-CD8 + T  cells, 
or a randomly leaky, nonselected CD4-CD8 + T cell reper- 
toire in B2m  -/-  mice (explanations a and b above), this 
model predicts a bias for self-MHC class I of the CTL reper- 
toire in Bzm  -/-  mice. This is in line with what we ob- 
served  in  terms of H-2  b cross-reactive  responses.  It must 
then be assumed that low levels of free MHC class I heavy 
chains are used in positive and negative selection processes 
in Bzm  -/-  mice. This is well in line with available data 
showing that low levels of MHC class I free heavy chains 
indeed can be expressed on calls of Bzm -/-  mice (10, 11). 
It is important to remember that as little as 200 MHC class 
I/peptide complexes on the surface of a target cell may trigger 
CTL lysis (34), and it may be that comparable numbers of 
free MHC class I heavy chains can trigger selection signals. 
Note that the CD8 + T  cells of ~zm  -/-  mice were not 
generally cross-reactive, but showed a bias for H-2  b. In ad- 
dition, this required MHC class I expression at normal levels 
with B2m; the mice were tolerant to ~2m -/-  cells of H-2  b 
genotype, although these transport heavy chains to the cell 
surface that can be recognized by CD8 + CTL with allo- 
specificity for H-2K  b or H-2D  b (10, 11). These observations 
suggest that the small pool of CD8 + T ceils in these mice 
does not just represent random "leaking" but rather the con- 
669  Glas et al. 
sequence of negative and positive selection of TCR on low 
levels of free H-2  b MHC class I heavy chains. The determi- 
nation of CD4 vs. CD8 phenotype of the T cells may still 
be based on a partly stochastic and partly selective process, 
as discussed recently (35,  36). 
We suggest that in relation to self-MHC class I expressed 
with 132m at normal density,  the skewed T  cell selection 
window of/32m  -/-  mice has  neglected a  lot  of the 
"useful" clones, while it failed to eliminate and rather posi- 
tively selected the "harmful" ones (37). The repertoire is how- 
ever only harmful in relation to normal levels of class I mole- 
cules, and adequate in relation to the 13zm -/-  self. 132m 
-/-  CTL could thus distinguish between allo and self-MHC 
class I in 13zm -/-  cells, but not when expressed at normal 
ligand  density in  132m-positive cells. The importance of 
ligand density is illustrated by the reduced sensitivity of 
RMA-S compared with RMA and also by the enhanced sen- 
sitivity of RMA-S after incubation at reduced temperature 
or in the presence of H-2-binding peptides. 
In addition to effects of low ligand density, there could 
also be qualitative effects due to the reduced ability of free 
MHC class I heavy chains on selecting cells in •2m  -/- 
to present and tolerize for specific self-peptides  (including 
peptides derived from the 132m molecule itself).  CD8 + T 
cells specific for self-peptides might thus escape elimination, 
which would contribute to the cross-reactivity  on cells ex- 
pressing H-2  b class I molecules in association with/32m and 
peptide. It has been reported that CTL reactive against self- 
peptides can be detected in the periphery of normal mice, 
only being reactive when target cells express an unphysio- 
logically high density of a peptide/MHC complex, i.e., when 
they are supplied with large amounts of peptides exogenously 
(38).  In our system, however,  the reactivity of 132m -/- 
CTL towards peptide loading-deficient RMA-S, T2-K  b, and 
T2-D  b cells argues against this qualitative model as the only 
explanation for the data. The data rather suggest that TCR 
affinity for self-MHC class I of B2m -/-  CTL can be pep- 
tide independent. This is important for understanding of 
TCR-MHC class I interactions as well as the positively selected T cell repertoire.  However, even if the/jam -/-  CTL have 
TCRs capable of binding to empty H-2K  b and H-2D  b mol- 
ecuhs, this does not necessarily mean that they have been 
selected on such molecules. If specific sdf-peprides are involved 
in positive selection,  one would predict that these peptides 
should dramatically increase the killing of H-2  b targets by 
the/jam  -/-  CTL. 
The observations on chimeric mice show that the anti- 
sdf-MHC crossreactivity  is not a consequence of the/jzm/ 
MHC class I-deficient status of the CTL themselves. After 
maturing in the presence of normal/jam-positive calls, they 
behaved as normal CTL. This could be due to the influence 
of radioresistant  nonhematopoetic cells, or of equally radi- 
oresistant bone marrow-derived cells of host type. Cells of 
the latter type are considered responsible for negative sdec- 
tion in chimeras studied within a couple of months of recon- 
stitution (29). 
How can these results and this model be reconciled with 
the initially reported absence of CD8 + T cells and CTL re- 
sponses in lJam -/-  mice? Scrutiny of the previously pub- 
lished data reveals CD8 staining of 1-2% of the spleen cells 
in such mice. This may be considered dose to background, 
especially if a modest number of cells analyzed  yield only 
a few uncertain dots in a FACS  |  plot. It may however repre- 
sent 1-3  x  106 cells in the spleen only, and a mere 10-25- 
fold reduction in number compared with wild type mice. 
This is a small reduction, considering that the frequency of 
precursors for H-2-restricted responses against viral or minor 
histocompatibility antigens are 20-200-fold lower than the 
frequency of allo H-2-specific precursors (39). Yet, the former 
give rise to strong in vivo responses capable of dearing virus 
infections and rejecting millions of tumor cells. They also 
yield strong cytotoxic responses in vitro, although these show 
a strict requirement for in vivo priming,  just as the allospecific 
responses in the present study of/jzm  -/-  mice. We con- 
clude that the search for CD8 + cells and of CTL responses 
in immunodeficient mice should include FACS  |  analysis of 
a large number of cells as well as an in vivo priming step 
in functional studies. According to this view, the status of 
MHC class I-restricted cells in several gene knock out mice 
may still offer some surprises.  There is for example an in- 
teresting possibility of a similar skewed repertoire selected 
on low levels of empty class I molecules in TAPl-deficient 
mice (40). 
It is possible that the relatively "normal" phenotype and 
immune resistance of/j2m -/-  mice partly depends on free 
MHC class I heavy chains substituting for complete MHC 
class I complexes, thus generating a skewed CTL repertoire 
whose responses may not always be detected in the conven- 
tional in vitro assays. Although we failed to generate B2m 
-/-  CTL using/j2m-deficient cells for priming in one 
combination, this needs further testing under conditions of 
adequate costimulation conditions, e.g., during the inflam- 
matory response during a virus infection. Only CD4 + CTL 
have been reported in/j2m  -/-  infected mice so far (17). 
Note that/jam  -/-  CTL could kill/j2m-deficient targets 
when  they had been  induced by/jam-positive allogeneic 
priming cells (Table 4). 
One reflection emerging from the proposed model con- 
cerns  the flexibility  of the immune system  as the T  cell 
precursor repertoire meets the selection machinery of the host 
and adapts to perform optimally in this environment. Even 
if the latter is MHC class I deficient as perceived by FACS  | 
T cells apparently detect enough to go through the selection 
procedure, illustrating the fine tuning required when setting 
the  limits  of avidity  for  positive  and  negative selection 
windows. Finally, it is a common view that positive selec- 
tion must bias the repertoire for binding to self-MHC ir- 
respective of antigen, but this has been difficult to demon- 
strate. Even if conventional T  cells can show a heteroclitic 
response on third party targets,  they do not kill self (25). 
Our results provide a demonstration of T  cell recognition 
of self-class  I  products,  even when expressed  in peptide 
loading-deficient cells. This system may serve as a tool to 
further analyze the self-MI-IC bias of the T cell repertoire, 
a somewhat unexpected development for the first  "MHC 
deficient" mice. 
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